Healthcare Contract Manufacturing Market Worth $512.7 Billion By 2030

Healthcare Contract Manufacturing Industry Overview

The global healthcare contract manufacturing market size was valued at USD 211.9 billion in 2021 and is projected to expand at a compound annual growth rate (CAGR) of 9.6% from 2022 to 2030. An increase in offshoring, especially in emerging countries, and the changing regulatory landscape, are the prominent trends currently present in the market. Pharmaceutical and medical device companies are outsourcing low-end services to third parties (CMOs) to reduce the overall cost of production and speed up the time to market of products. This trend is expected to contribute to the growth of the contract manufacturing market in the foreseeable future. COVID-19 brought in unparalleled demand for diagnostic tests, Personal Protective Equipment (PPE), ventilators, and other critical medical supplies. COVID-19 has had a major impact on the supply-demand gap, with a 1,000 to 2,000-fold increase for PPE products, raw material shortages increased by over 10% thereby pushing the by more than 100% in 2020.

The COVID-19 pandemic has forced many pharmaceutical and medical device companies to increase the manufacturing of drugs and medical devices needed by infected patients worldwide. The U.S. FDA has observed that over 60% of FDA-regulated products imported from China are medical devices, making U.S. medical device industry highly dependent on China’s supply chain. Medical device manufacturers are facing severe supply bottlenecks, which will ultimately reduce the company’s scope of revenue generation.

Gather more insights about the market drivers, restrains and growth of the Global Healthcare Contract Manufacturing market

 

The presence of end-to-end service providers that are engaged in providing value-added services for an integrated or risk-sharing business model is expected to boost the market growth. Pharmaceutical and medical device companies are outsourcing manufacturing activities to CMOs to reduce their manufacturing footprint. It allows manufacturers to be more dynamic and cost-effective in their manufacturing process.

In addition, factors such as the increasing prevalence of noninvasive surgical procedures are driving the demand for pharmaceutical drugs and medical devices. To meet such increased demand, OEMs are outsourcing the manufacturing of non-core manufacturing activities as it assists them in reducing labor costs, freeing up capital, increasing worker productivity, and improving manufacturing lead times. For many large, medium and small pharma firms, outsourcing turns out to be an economic option, as fixed costs for manufacturing biologics products account for around 60–70% of the Cost of goods sold (COGS) and cannot be avoided even during idle conditions.

Therefore, the use of multi-product facilities to produce biologics has been proven economically efficient and safe as there is negligible to no risk with respect to product carryover, thereby supporting market growth. Since the medical device industry is highly regulated, making rapid changes in the supply chain may not be manageable. Medical device manufacturers distributing products in the U.S. are not required to report actual or potential supply chain shortages to the FDA. Despite this, the FDA is actively addressing potential shortages in the medical device supply chain. Some of the products facing shortage are aluminum products, integrated circuits, lithium-ion batteries, and special components, including pneumatic fittings, black body radiation source, & platinum.

This has created an unprecedented demand for the manufacturing of active pharmaceutical ingredients (APIs), finished doses, and medical devices in order to maintain supply. According to Medical Product Outsourcing, manufacturers expect outsourcing to yield cost savings and faster time to market. According to various reputed tabloids, companies are expected to outsource more work, based on a 2020 Global Managed Services Report. This report has performed a survey with 1,250 executives across 29 countries, which stated that 45% of organizations will outsource more in the coming years. However, the limited production capacity of CMOs may pose a major challenge restraining the market growth.



Browse through Grand View Research's Medical Devices Industry Research Reports.

  • Cochlear Implant Market - The global cochlear implant market size was valued at USD 1.5 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 8.71% from 2022 to 2030. The growing prevalence of hearing loss and increase in adoption due to technological advancements are the factors expected to drive the growth of the market.

 

  • Intraoperative Neuromonitoring Market - The global intraoperative neuromonitoring market size was valued at USD 3.02 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 4.9% from 2022 to 2030.

 

Healthcare Contract Manufacturing Market Segmentation

Grand View Research has segmented the global healthcare contract manufacturing market based on type and region:

Healthcare Contract Manufacturing Type Outlook (Revenue, USD Billion, 2017 - 2030)

  • Medical Device
    • By Service
      • Accessories Manufacturing
      • Assembly Manufacturing
      • Component Manufacturing
      • Device Manufacturing
    • By Therapeutic Area
      • Cardiology
      • Diagnostic imaging
      • Orthopedic
      • IVD
      • Ophthalmic
      • General & plastic surgery
      • Drug delivery
      • Dental
      • Endoscopy
      • Diabetes care
      • Others
    • Pharmaceutical
      • By Service
        • API/Bulk Drugs
        • Advanced Drug Delivery Formulations
        • Packaging
        • Finished Dose Formulations
          • Solid
          • Liquid
          • Semi-solid formulations

Healthcare Contract Manufacturing End use Outlook (Revenue, USD Billion, 2017 - 2030)

  • Medical Device Companies
  • Pharmaceutical Companies
  • Biopharmaceutical Companies

Healthcare Contract Manufacturing Regional Outlook (Revenue, USD Billion, 2017 - 2030)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)


Market Share Insights

  • February 2020: Integer Holdings Corporation acquired Inomec, an Israel-based company. The acquisition is likely to provide Integer with an R&D & sales center in Israel and would add catheter design, clinical, & pilot manufacturing capabilities to its portfolio.

  • May 2018: Jabil opened a Nypro healthcare manufacturing facility in Hungary. This initiative permitted Nypro, a Jabil company, to expand its manufacturing capabilities in Europe's life sciences and advanced human diagnostics markets.

 

Key Companies profiled:

Some prominent players in the global healthcare contract manufacturing market include:

  • Nordson Corporation
  • Integer Holdings Corporation
  • Jabil Inc.
  • Viant Technology LLC
  • FLEX LTD.
  • Celestica Inc.
  • Sanmina Corporation
  • Plexus Corp.
  • Phillips-Medisize
  • West Pharmaceutical Services, Inc.
  • Synecco
  • Catalent, Inc.
  • Thermo Fisher Scientific Inc.
  • Recipharm
  • Boehringer Ingelheim International GmbH
  • Lonza
  • Samsung Biologics
  • WuXi AppTec
  • FUJIFILM Diosynth Biotechnologies
  • Cambrex Corporation

 

Order a free sample PDF of the Healthcare Contract Manufacturing Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

 

Comments

Post a Comment

Popular posts from this blog

Breast Pump and Breastfeeding Accessories Market Updates and Projections

  Breast Pump And Breastfeeding Accessories Industry Data Book | Forecast 2030 Breast Pump And Breastfeeding Accessories Industry Data Book - Breast Pump, Wearable Breast Pump & Breastfeeding Accessories Market Grand View Research’s breast pump & breastfeeding accessories industry data book is a collection of market sizing information & forecasts, regulatory data, reimbursement structure, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research.   Access the Global Breast Pump And Breastfeeding Accessories Industry Data Book, 2023 to 2030 , compiled with details like market sizing information & forecasts, trade data, pricing intelligence, competitive benchmarking, macro-environmental analyses, and regulatory ...
Read more

Spectrometry Sector: Emerging Technologies 2023-2030

  Spectrometry Industry | Forecast 2030 Spectrometry industry data book is a combination of the market data from five reports namely, spectrometry, mass spectrometry, NMR spectroscopy, near-infrared spectroscopy, and in-line UV-vis spectroscopy market. The market was valued at USD 17.4 billion in 2021 with a CAGR of 7.34% during 2022-2030. NMR spectroscopy market and Near-infrared Spectroscopy market are also growing at the CAGR of 5.1% and 6.08% respectively. The development of advanced spectrometry instruments and consumables is anticipated to create growth opportunities in this market and drive the market in the coming years.   Access the Global Spectrometry Industry Data Book, 2024 to 2030 , compiled with details like market sizing information & forecasts, trade data, pricing intelligence, competitive benchmarking, macro-environmental analyses, and regulatory & technological framework studies   Spectrometry holds significant potential in the near future o...
Read more

Endoscopy Devices Market Predicted to Witness Strong Growth from 2023 to 2030

  Endoscopy Devices Industry | Forecast 2030 The global endoscopy devices market was valued at USD 50.8 Billion in 2022 and is anticipated to grow at a CAGR of 7.5% over the forecast period. The market growth is attributed to the presence of cost-effective pre and post-procedures and increasing awareness regarding the minimal invasive properties of the devices. COVID-19 has impacted the market negatively as the number of endoscopic procedures reduced owing to the postponed and canceled elective and semi-urgent procedures. However, the increasing geriatric population, coupled with the rising burden of chronic diseases, is anticipated to drive the market. Furthermore, increasing the preference for disposable endoscopic equipment reduce the possibility of cross-contamination is anticipated to drive the market over the forecast period.   Access the Global Endoscopy Devices Industry Data Book, 2023 to 2030 , compiled with details like market sizing information & forecasts, ...
Read more